Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Pentoxifylline96 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04063 | 33772456 | Indian J Gastroenterol | Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study. | 2021 | Details |
| A05147 | 33354924 | Basic Clin Pharmacol Toxicol | The effect of acetylsalicylic acid and pentoxifylline in guinea pigs with non-alcoholic steatohepatitis. | 2021 | Details |
| A05407 | 33269017 | J Med Biochem | Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis. | 2020 | Details |
| A06984 | 32673798 | Mol Metab | Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis. | 2020 | Details |
| A08502 | 32083947 | Can J Physiol Pharmacol | Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study. | 2020 | Details |
| A08851 | 31965945 | Curr Drug Discov Technol | Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. | 2021 | Details |
| A09070 | 31885103 | Fundam Clin Pharmacol | Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats. | 2020 | Details |
| A12660 | 30341231 | Postgrad Med J | Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. | 2018 | Details |
| A14850 | 29204050 | World J Gastroenterol | Current and emerging pharmacological therapy for non-alcoholic fatty liver disease. | 2017 | Details |
| A15082 | 29106066 | J Dig Dis | Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence. | 2017 | Details |
| A15120 | 29085788 | J Transl Int Med | Effect of Pentoxifylline on Histological Activity and Fibrosis of Nonalcoholic Steatohepatitis Patients: A One Year Randomized Control Trial. | 2017 | Details |
| A15124 | 29085205 | World J Gastroenterol | Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. | 2017 | Details |
| A15285 | 28987260 | Clin Liver Dis | Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15830 | 28691103 | J Clin Transl Res | Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. | 2017 | Details |
| A16109 | 28565851 | Exp Ther Med | Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline. | 2017 | Details |
| A16420 | 28404113 | Lancet Gastroenterol Hepatol | Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. | 2016 | Details |
| A16488 | 28358980 | Cochrane Database Syst Rev | Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. | 2017 | Details |
| A16628 | 28276774 | Expert Rev Clin Pharmacol | Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A17704 | 27646933 | Gut | Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. | 2016 | Details |
| A17767 | 27612024 | Sci Rep | Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. | 2016 | Details |
| A17814 | 27564402 | Expert Opin Pharmacother | Emerging and future therapies for nonalcoholic steatohepatitis in adults. | 2016 | Details |
| A17870 | 27512874 | Medicine (Baltimore) | Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis. | 2016 | Details |
| A18220 | 27277347 | Mymensingh Med J | Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients. | 2016 | Details |
| A18539 | 27063274 | Clin Liver Dis | Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18661 | 27006654 | Gastroenterol Res Pract | A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. | 2016 | Details |
| A18671 | 27003143 | Dig Dis Sci | Novel Pharmacotherapy Options for NASH. | 2016 | Details |
| A18785 | 26942734 | Dig Dis Sci | Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18980 | 26834792 | Hepat Mon | Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran. | 2015 | Details |
| A19143 | 26730275 | World J Hepatol | Management of non-alcoholic fatty liver disease in 2015. | 2015 | Details |
| A19186 | 28670148 | Clin Med Insights Ther | Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. | 2016 | Details |
| A19494 | 26523207 | World J Hepatol | Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice. | 2015 | Details |
| A19745 | 26378648 | Semin Liver Dis | Pharmacotherapy for Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19930 | 26258810 | Eur J Cancer Prev | Pentoxifylline prevents nonalcoholic steatohepatitis-related liver pre-neoplasms by inhibiting hepatic inflammation and lipogenesis. | 2016 | Details |
| A20055 | 26189925 | Hepatology | Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis. | 2015 | Details |
| A20450 | 25956613 | Hepatol Int | Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20527 | 25910299 | Turk J Gastroenterol | A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis. | 2014 | Details |
| A20610 | 25852263 | World J Gastroenterol | Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2015 | Details |
| A21231 | 25468788 | Med Hypotheses | Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C. | 2014 | Details |
| A21497 | 25274101 | Br J Nutr | Non-alcoholic fatty liver disease: need for a balanced nutritional source. | 2014 | Details |
| A22218 | 24743504 | Eur J Gastroenterol Hepatol | Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. | 2014 | Details |
| A22253 | 24717764 | Curr Opin Gastroenterol | State of the art: treatment of nonalcoholic steatohepatitis. | 2014 | Details |
| A22410 | 24605610 | Lik Sprava | [Microcirculatory changes of gastric mucosa in patients with chronic H. pylori-associated erosive gastritis with non-alcoholic steatohepatitis during treatment]. | 2013 | Details |
| A22443 | 24574727 | World J Gastroenterol | Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis. | 2014 | Details |
| A24135 | 25755455 | J Clin Exp Hepatol | A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis. | 2012 | Details |
| A24229 | 23075871 | Dig Dis | Clinical spectrum and therapy of non-alcoholic steatohepatitis. | 2012 | Details |
| A24251 | 23075296 | Ital J Pediatr | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. | 2012 | Details |
| A24655 | 25755424 | J Clin Exp Hepatol | Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis. | 2012 | Details |
| A24746 | 22541706 | Clin Liver Dis | Nonalcoholic fatty liver disease. | 2012 | Details |
| A24780 | 22505276 | Hepatology | Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. | 2012 | Details |
| A24953 | 22319522 | Exp Diabetes Res | Pentoxifylline attenuates methionine- and choline-deficient-diet-induced steatohepatitis by suppressing TNF-α expression and endoplasmic reticulum stress. | 2012 | Details |
| A25520 | 21748765 | Hepatology | Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. | 2011 | Details |
| A25533 | 21740407 | Br J Pharmacol | Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. | 2012 | Details |
| A25592 | 21677329 | Ann Hepatol | Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. | 2011 | Details |
| A25683 | 21549113 | Eur J Pharmacol | Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. | 2011 | Details |
| A25755 | 21477300 | Lipids Health Dis | Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A26350 | 20608031 | Lik Sprava | [Efficiency of complex therapy in the treatment of non-alcoholic steatohepatitis and prevention of liver fibrosis]. | 2010 | Details |
| A26370 | 20578268 | Hepatology | A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
| A26761 | 19818312 | Clin Liver Dis | Pharmacologic therapy of non-alcoholic steatohepatitis. | 2009 | Details |
| A26967 | 19446916 | J Hepatol | Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. | 2009 | Details |
| A27789 | 17444848 | J Gastroenterol Hepatol | Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. | 2007 | Details |
| A28068 | 16531961 | Ann Hepatol | Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. | 2006 | Details |
| A28112 | 16393299 | Aliment Pharmacol Ther | Review article: Drug therapy for non-alcoholic fatty liver disease. | 2006 | Details |
| A28365 | 15464239 | J Hepatol | Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. | 2004 | Details |
| A28842 | 34919247 | Eur Rev Med Pharmacol Sci | A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients. | 2021 | Details |
| A35397 | 20835270 | Acta Pharmacol Sin | Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression. | 2010 | Details |
| A36294 | 19669304 | Hepatol Int | A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH). | 2008 | Details |
| A36698 | 17436095 | Dig Dis Sci | Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis. | 2007 | Details |
| A36707 | 17415655 | Dig Dis Sci | Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet. | 2007 | Details |
| A36711 | 17410287 | J Gastrointestin Liver Dis | Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. | 2007 | Details |
| A36858 | 17064471 | Zhonghua Gan Zang Bing Za Zhi | [Effects of pentoxifylline on hepatic nuclear factor-kappa B signaling pathway and insulin resistance in nonalcoholic steatohepatitis rats induced by fat-rich diet]. | 2006 | Details |
| A37487 | 15571584 | Am J Gastroenterol | A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. | 2004 | Details |
| A37549 | 15447754 | Am J Gastroenterol | Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. | 2004 | Details |
| A44260 | 29210655 | Curr Vasc Pharmacol | Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis. | 2018 | Details |
| A45827 | 22505349 | Hepatology | The mechanism behind the novel fibrosis recently described in NASH in HEPATOLOGY 2011 and elsewhere. | 2012 | Details |
| A45925 | 22045667 | Hepatology | Pentoxifylline for steatohepatitis: magic bullet or smoking gun? | 2011 | Details |
| A46796 | 15349802 | Semin Liver Dis | Diagnosis and therapy of alcoholic liver disease. | 2004 | Details |
| A46818 | 14720455 | Curr Gastroenterol Rep | New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments. | 2004 | Details |
| A47018 | 29708448 | Expert Opin Pharmacother | Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. | 2018 | Details |
| A47137 | 25278689 | World J Gastroenterol | Alcoholic liver disease: treatment. | 2014 | Details |
| A47161 | 24656653 | Gastroenterol Hepatol | Alcoholic hepatitis: Prognosis and treatment. | 2014 | Details |
| A47183 | 23958271 | Trials | Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. | 2013 | Details |
| A47187 | 23799218 | J Gastrointestin Liver Dis | Update on the management of alcoholic steatohepatitis. | 2013 | Details |
| A47205 | 22988723 | Rev Med Suisse | [Alcoholic steatohepatitis: what's new in 2012?]. | 2012 | Details |
| A47224 | 22356308 | J Dig Dis | Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. | 2012 | Details |
| A47258 | 20955970 | Best Pract Res Clin Gastroenterol | Alcoholic steatohepatitis. | 2010 | Details |
| A47319 | 17203086 | Nat Clin Pract Gastroenterol Hepatol | Management strategies in alcoholic liver disease. | 2007 | Details |
| A48207 | 19760953 | Hepatogastroenterology | Effects of lovastatin and pentoxyphyllin in nonalcoholic steatohepatitis. | 2009 | Details |
| A48530 | 34647189 | Diabetes Ther | Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant? | 2021 | Details |
| A48599 | 33326633 | Aliment Pharmacol Ther | The diagnostic and prognostic significance of liver histology in alcoholic hepatitis. | 2020 | Details |
| A48610 | 33156105 | Am J Gastroenterol | In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers. | 2020 | Details |
| A48733 | 30338039 | Oncotarget | Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colon. | 2018 | Details |
| A48885 | 25603848 | Korean J Gastroenterol | [Diagnostic and therapeutic strategies for severe alcoholic hepatitis]. | 2015 | Details |
| A49040 | 20455447 | Lik Sprava | [Correction of microcirculation disorder in the liver of patients with non-alcoholic steatohepatitis]. | 2010 | Details |
| A49060 | 19646832 | Gastroenterol Clin Biol | Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial. | 2009 | Details |
| A49905 | 35602098 | Oxid Med Cell Longev | A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases. | 2022 | Details |
| A51851 | 33680863 | Toxicol Rep | Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy. | 2021 | Details |